CardioNet Announces Public Offering of Common Stock
July 22 2008 - 6:50AM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical
technology company with an initial focus on the diagnosis and
monitoring of cardiac arrhythmias, announced an underwritten public
offering of 4,664,102 shares of common stock by certain of
CardioNet�s existing stockholders. The selling stockholders plan to
grant to the underwriters an option to purchase from them an
additional 699,615 shares to cover over-allotments, if any.
CardioNet will not be selling any shares of common stock in the
offering and will not receive any of the proceeds from the sale of
shares by the selling stockholders. Citi is the sole book-running
manager, Banc of America Securities LLC and Leerink Swann are the
co-lead managers and Cowen and Company and Thomas Weisel Partners
LLC are the co-managers for this offering. A prospectus relating to
these securities may be obtained from the Prospectus Department of
Citi by calling (800) 831-9146, by emailing
batprospectusdept@citigroup.com or by writing to Brooklyn Army
Terminal, 140 58th Street, 8th Floor, Brooklyn, NY 11220. A
registration statement relating to these securities has been filed
with the Securities and Exchange Commission but has not yet become
effective. These securities may not be sold nor may offers to buy
be accepted prior to the time the registration statement becomes
effective. This communication shall not constitute an offer to sell
or the solicitation of an offer to buy nor shall there be any sale
of these securities in any state in which such offer, solicitation
or sale would be unlawful prior to registration or qualification
under the securities laws of any such state. Statements in this
press release that are not strictly historical are
"forward-looking" statements within the meaning of the Private
Securities Litigation Reform Act of 1995 and involve a high degree
of risk and uncertainty. In particular, due to market conditions or
otherwise the selling stockholders may be unable to complete the
sale of common stock under the registration statement, and, even if
such sale is completed, the underwriters for the offering may not
exercise any portion of the over-allotment option. About CardioNet
CardioNet is the leading provider of ambulatory, continuous,
real-time outpatient management solutions for monitoring relevant
and timely clinical information regarding an individual's health.
CardioNet's initial efforts are focused on the diagnosis and
monitoring of cardiac arrhythmias, or heart rhythm disorders, with
a solution that it markets as the CardioNet System. More
information can be found at http://www.cardionet.com.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024